cetylpyridinium chloride anhydrous and azacitidine

cetylpyridinium chloride anhydrous has been researched along with azacitidine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ballestar, E; Blanco, B; Caballero-Velazquez, T; Calderón, C; Cañizo, C; Carrancio, S; Ciudad, L; de la Rica, L; Gutierrez-Cosío, S; Herrero-Sánchez, C; Pérez-Simón, JA; San Miguel, JF; Sánchez-Abarca, LI; Santamaría, C	1

Other Studies

1 other study(ies) available for cetylpyridinium chloride anhydrous and azacitidine

Article	Year
Epigenetic regulation of PRAME in acute myeloid leukemia is different compared to CD34+ cells from healthy donors: effect of 5-AZA treatment. Leukemia research, 2012, Volume: 36, Issue:7 Topics: Antigens, CD34; Antigens, Neoplasm; Antimetabolites, Antineoplastic; Azacitidine; Biomarkers, Tumor; Blood Donors; Bone Marrow Cells; Cells, Cultured; CpG Islands; Cytogenetic Analysis; Epigenesis, Genetic; Gene Expression Regulation, Leukemic; Health; Humans; Leukemia, Myeloid, Acute; Stem Cells	2012

Article

Year

Epigenetic regulation of PRAME in acute myeloid leukemia is different compared to CD34+ cells from healthy donors: effect of 5-AZA treatment.

Leukemia research, 2012, Volume: 36, Issue:7

Topics: Antigens, CD34; Antigens, Neoplasm; Antimetabolites, Antineoplastic; Azacitidine; Biomarkers, Tumor; Blood Donors; Bone Marrow Cells; Cells, Cultured; CpG Islands; Cytogenetic Analysis; Epigenesis, Genetic; Gene Expression Regulation, Leukemic; Health; Humans; Leukemia, Myeloid, Acute; Stem Cells

2012